<DOC>
	<DOCNO>NCT01985880</DOCNO>
	<brief_summary>The purpose study evaluate efficacy biomarker patient interstitial cystitis/painful bladder syndrome</brief_summary>
	<brief_title>The Efficacy Biomarker Patient With Interstitial Cystitis/Painful Bladder Syndrome</brief_title>
	<detailed_description>This observational study</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<criteria>1 ) must experience bladder pain , urinary urgency urinary frequency , least 6 month prior entry study 2 ) Pain VAS ≥4 3 ) O'LearySant Interstitial Cystitis questionnaire ( ICQ ) symptom problem ≥ 12 ( pain ≥2 , nocturia ≥ 2 ) 4 ) PUF score ≥ 13 5 ) cystoscopic record within 2 year 1 . Patients pregnancy , childbearing age without contraception 2 . Patients void volume &lt; 40 , &gt; 400ml 3 . Patients microscopic hematuria , ( ≥1+ dipstick ) , If exclude evidence neoplastic tumor examination 4 . Patients urine culture show evidence urinary tract infection 1month prior study 5 . Accompanied medical problem Tuberculosis urinary system Bladder cancer , urethral cancer , prostate cancer Recurrent cystitis anatomical disorder 6 . Patients prior surgery ( eq , bladder augmentation , cystectomy 7 . Patients neurologic disorder 8 . Patients indwell catheter intermittent selfcatheterization 9 . Patients psychologic problem</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Biomarkers</keyword>
</DOC>